Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
De plaats van de Calcium Score in het Atrium Medisch Centrum 2-5-2017 ©Eduard van den Berg, cardio.nl 1 CVRM ESC 2012 2-5-2017 Eduard van den Berg, cardio.nl 2 Decrease † in about 10 yrs 2-5-2017 Eduard van den Berg, cardio.nl 3 NICE report According to the report of NICE, implementation of the population approach may bring numerous benefits and savings: † Narrowing the gap in health inequalities. † Cost savings from the number of CVD events avoided. † Preventing other conditions such as cancer, pulmonary diseases, and type 2 diabetes. † Cost savings associated with CVD such as medications, primary care visits, and outpatient attendances. † Cost savings to the wider economy as a result of reduced loss of production due of illness in those of working age, reduced benefit payments, and reduced pension costs from people retiring early from ill health. † Improving the quality and length of people’s lives. 2-5-2017 Eduard van den Berg, cardio.nl 4 A Rosetta Stone for Coronary Calcium Risk Stratification: Agatston, Volume, and Mass Scores in 11,490 Individuals When we matched them against a known “lesion” phantom, the Agatston and volume scores behave nonlinearly, and the latter grossly overestimates volume. The mass method is linear except for lesions near the edge of detectability and matches known volumes to within a small percentage. CONCLUSION. We provide validated risk stratification data for use with mass scoring methods. AJR American Journal of roentgenology http://www.ajronline.org/content/181/3/743.full John A. Rumberger1 and Leon Kaufman2,3 2-5-2017 © Eduard van den Berg, cardio.nl 8 Why percentile ranking The actual calcium score, although an indicator of overall disease extent [7], may not be as useful for predicting coronary events as its percentile ranking. even small scores that are much higher than those anticipated for age and sex may be better predictors of risk. For instance, a calcium score of 40 in a 40-year-old man would place him well above the 95th percentile and engender a risk of a cardiac event during the next 3-6 years that may well exceed that of a 70-year-old with a similar score, who would rank for that age group below the 10th percentile. a calcium score above the 75th percentile for age and sex may increase heart risk an order of magnitude above that for individuals with scores below the 25th percentile [8, 9]. 2-5-2017 Eduard van den Berg, cardio.nl 9 2-5-2017 © Eduard van den Berg, cardio.nl 10 2-5-2017 © Eduard van den Berg, cardio.nl 11 Agatston scale The Agatston scale calculates a calcium burden by multiplying the area of the lesion above a 130-H threshold (obtained from 3-mm-thick nonoverlapped slices) by a weighting factor that is dependent on the peak signal anywhere in the lesion. Because of the discrete nature of the weighting, the Agatston score is sensitive to noise when the peak signal is near one of the threshold values and completely insensitive away from them. H = Hounsefield units Considering that newer multi slice MDCT scanners can image the heart with much less slice thickness, nothing in the Agatston rules allows for a consistent computational method to translate a measurement from one scanner to another in a consistent fashion. In other words, the Agatston method is not portable from one centre to another. 2-5-2017 Eduard van den Berg, cardio.nl 12 Volume score the volume score was introduced by Callister et al. [12]. The volume score linearly interpolates the data set to isotropic volumes and, as its name implies, computes the volume of the lesion above a 130-H threshold (the nominal threshold for calcification derived from observational studies). the volume method, contrary to what its name implies, does not measure a value purely dependent on volume; it is affected by calcium content and by scanner operating parameters. Even when the latter are held fixed, the volume score reflects both lesion volume and calcium content. Its portability is affected by the same issues that affect the Agatston method. 2-5-2017 Eduard van den Berg, cardio.nl 13 Mass measurement methods Basically, these consist of integration of the signal for pixels above a given threshold. For a well-calibrated CT scanner, in the absence of noise, this integration (scaled by pixel volume) gives the total mineral content independently of slice thickness and spatial resolution. In practice, the threshold necessary to avoid the inclusion of false-positive pixels changes the measurement. Another issue of mass methods is what mass is being expressed; calcified lesions include a complex of different calcium bone ash equivalent or calcium equivalent. Whereas each will give a different result, all these are different scaling factors for the integral of the Hounsfield values so that the different measures are easily related to each other. If the scaling factor is given, translation is possible. With suitably low threshold settings, the mass methods come closest to being portable. 2-5-2017 © Eduard van den Berg, cardio.nl 14 Chart shows age distribution population Chart shows age distribution for men (black bars) and women (white bars) of patients in this study. There were 11,490 patients, 63% male. 2-5-2017 Eduard van den Berg, cardio.nl 15 75th percentile range for men and women Graph shows comparison of results for 75th percentile range for men and women as reported in Hoff et al. [10] (Kondos database). 2-5-2017 © Eduard van den Berg, cardio.nl 16 Agatston and Volume scores men Graph shows volume scores for men. Graph shows Agatston scores for men. 2-5-2017 © Eduard van den Berg, cardio.nl 17 Volume and Mass scores men Graph shows volume scores for men. 2-5-2017 Graph shows mass scores (bone ash equivalent) for men. Eduard van den Berg, cardio.nl 18 Agatston and Volume scores Women Graph shows Agatston scores for women. 2-5-2017 Graph shows volume scores for women © Eduard van den Berg, cardio.nl 19 Volume and mass scores women Graph shows volume scores for women 2-5-2017 Graph shows mass scores (bone ash equivalent) for women. Eduard van den Berg, cardio.nl 20 reproducibility Graph shows reproducibility of three scoring methods in 35 patients. Approximately 50% of all nonzero scores fall within 25% reproducibility. Mean is 38% for all three methods. There is no significant difference among them. Black bars = Agatston score, white bars = volume score, gray bars = mass score. 2-5-2017 © Eduard van den Berg, cardio.nl 21 Conclusion Agatston – Mass - Volume The single advantage of the mass method is its better reflection of the physical properties of the lesion and, consequently, better adaptation to portability across and between CT scanners. Most widely used in the Netherlands is the Agatston score 2-5-2017 Eduard van den Berg, cardio.nl 22 Agatston Score Men and Women Graph shows Agatston scores for men. 2-5-2017 Graph shows Agatston scores for women. © Eduard van den Berg, cardio.nl 23 Percentile Percentile rank is calculated by adjusting calcium scores for age and sex. The following example illustrates how to read the next tables: a 57-year-old man with a calcium score of 54 would be in the 50th percentile. This means that, in his age- and sex-matched group, 50% of men have calcium scores greater than his and 50% have scores less than his score. A 46-year-old woman with a calcium score of 2 would be in the 75th percentile. This means that compared with her age- and sex-matched peers, 75% have calcium scores less than hers and 25% have scores above her score of 2. 2-5-2017 Eduard van den Berg, cardio.nl 24 What calcium score is typical for a person my age men ? 2-5-2017 Eduard van den Berg, cardio.nl 25 What calcium score is typical for a person my age women ? 2-5-2017 Eduard van den Berg, cardio.nl 26 Recommendations I 2-5-2017 © Eduard van den Berg, cardio.nl 27 Recommendations II 2-5-2017 © Eduard van den Berg, cardio.nl 28 ACC/AHA GL First Calculate the Framingham traditional risk score 2-5-2017 © Eduard van den Berg, cardio.nl 29 AHA/ACC guidelines 2-5-2017 Eduard van den Berg, cardio.nl 30 Low Risk = < 1 % / yr, No test • When a calculator, such as the Framingham Risk Score, is used to evaluate risk, low risk would be defined as a risk of CAD events less than 1% per year. So if you are at low risk of a CAD event, there is NO need for coronary artery calcium scoring. 2-5-2017 Eduard van den Berg, cardio.nl 31 High Risk = > 2 % / yr, No test • Also, if you already have diabetes or peripheral vascular disease you are at high risk even if you have absolutely no symptoms of coronary artery disease and, again, knowing your calcium score in this setting adds nothing to understanding your risk. In other words, if a validated risk assessment tool, like the Framingham Risk Score, determines you’re at high risk of a CAD event, then you are at high risk — and there is NO need for coronary artery calcium scoring. 2-5-2017 © Eduard van den Berg, cardio.nl 32 Intermediate Risk = <2∧>1, Test • So, the best use of fast CT scanning for calcium scoring is in those individuals who are determined to be in the intermediate-risk category, which would apply to anyone whose Framingham Risk Score puts them at a 10-year risk of a CHD event of 10% to 20%. (Another way of stating this is that patients at intermediate risk are estimated to have a 1% to 2% risk of a CAD event every year.) 2-5-2017 © Eduard van den Berg, cardio.nl 33 Can you have EuroScore < 1%/yr ∧Ca-score up to 100 2-5-2017 © Eduard van den Berg, cardio.nl 34 Statements, accepted ? • Any calcium means coronary atherosclerosis • Score level = total atherosclerotic plaque burden ≠ severity particular stenosis • CS > 400 = P(at least one stenosis > 70 %) = 90 % • CS alone is a more powerful predictor of future events than all other RF combined • CS is independent of other CV-RF and a good predictor of † elderly • CS is related to CV events at other locations of the vascular tree • CS = 0 means P(sign sten man) = 0,7%, P(sign sten woman)=0,0% and P(Tl-201 = pos) = 0,0 % http://www.euroscore.org/calc.html http://www.newportbodyscan.com/CACrisk.htm http://www.chestx-ray.com/coronary/corcalc.html 2-5-2017 © Eduard van den Berg, cardio.nl 35 Questions • Is there a place for common sense next to guidelines, do you insist on having severe arguments not to follow the protocol ? • If a young (28) female FHC pt comes to you for screening because her sister of 32 died last week of an AMI (F † 48, M † 52, 2 / 4 F † < 45 yr, 1/3 S † < 40 all of CAD, most with CABG or PCI) and if she has no complaints or further RF, would you be satisfied with a negative adequate bicycle test, would you give her primary prevention medication, would you still do a CS and if CS = 0 would you than restrict to only chol synthese inhibitors. To say it another way do you believe in CS = 0 fot this woman means P(sign CAD) = 0 2-5-2017 © Eduard van den Berg, cardio.nl 36 2-5-2017 Eduard van den Berg, cardio.nl 37 HeartScore Europe upgraded with HDL, BMI and Risk Age Did you know...In addition to its standard assessment features, HeartScore Europe now includes: An HDL cholesterol function, which improves the accuracy of the model A Risk Age function, which will help patients quickly understand their exposure to overall CVD risk A ‘fast track’ calculator with Body Mass Index (BMI) https://escol.escardio.org/Heartscore/pmsCenter.aspx?model=EuropeHigh 2-5-2017 Eduard van den Berg, cardio.nl 38 2-5-2017 Eduard van den Berg, cardio.nl 39 Score Card 2012, no HDL Use the low risk charts in Andorra, Austria, Belgium*, Cyprus, Denmark, Finland, France, Germany, Greece*, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, The Netherlands*, Norway, Portugal, San Marino, Slovenia, Spain*, Sweden*, Switzerland and the United Kingdom. Use the high risk charts in other European countries. Of these, some are at very high risk and the charts may underestimate risk in these. These include Armenia, Azerbaijan, Belarus, Bulgaria, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Macedonia FYR, Moldova, Russia, Ukraine and Uzbekistan. *Updated, re-calibrated charts are now available for Belgium, Germany, Greece, The Netherlands, Spain, Sweden and Poland. 2-5-2017 Eduard van den Berg, cardio.nl 40 ESCardio.org 2012 Europe low risk (Belgium, France, Italy, Luxembourg, Switzerland and Portugal) Europe high risk (Albania, Algeria, Armenia, Austria, Belarus, Bulgaria, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, Georgia, Hungary, Iceland, Ireland, Israel, Latvia, Libanon, Libya, Lithuania, Former Yugoslav Republic of Macedonia, Moldova, Morocco, Norway, Romania, San Marino, Serbia and Montenegro, Slovakia, Slovenia, The Netherlands, Tunisia, Turkey, Ukraine, United Kingdom) 2-5-2017 Eduard van den Berg, cardio.nl 41 Interpretation Score High = > 1,5%/ yr, Intermediate = 1,0-1,5 %, Low = < 1,0 %/ yr 2-5-2017 Eduard van den Berg, cardio.nl 42 2-5-2017 Eduard van den Berg, cardio.nl 43 Reported Average Sensitivity & Specificity of Stress Tests Test modality 2-5-2017 Sensitivity Specificity • Non-Imaging ETT 65% • Nuclear ETT – Quantitative – Qualitative – Dipyridamole – RVG 87% 87% 90% 87% 87% 77% 90% 75% • Echo ETT 80% 87% Eduard van den Berg, cardio.nl 85% 44 Post-Test Probability of CAD Based on Pre-Test Symptoms - Women Women 40 - 49 100 100 90 90 80 80 % Probabilty CAD % Probabilty CAD Women 30 - 39 70 60 50 40 30 20 10 0 0.0 0.5 0.0 1.0 1.5 2.0 2.5 ST Depression mm None Non-Angina Atypical Angina 3.0 Typical Angina Women 50 - 59 100 90 80 70 60 50 40 30 20 10 0 0.5 1.0 1.5 2.0 2.5 ST Depression mm None Non-Angina Atypical Angina 3.0 Typical Angina Women 60 - 69 100 % Probabilty CAD % Probabilty CAD 90 0.0 0.5 1.0 1.5 Non-Angina 80 70 60 50 40 30 20 10 0 0.0 2.0 ST Depression mm None 70 60 50 40 30 20 10 0 Atypical Angina 2.5 0.5 3.0 1.0 1.5 2.0 ST Depression mm Typical Angina None Non-Angina Atypical Angina 2.5 3.0 Typical Angina Diamond and Forrester. N. Engl. J. Med. 1350-7, 1979 2-5-2017 Eduard van den Berg, cardio.nl 45 Post-Test Probability of CAD Based on Pre-Test Symptoms - Men Men 40 - 49 100 100 90 90 80 80 % Probabilty CAD % Probabilty CAD Men 30 - 39 70 60 50 40 30 20 10 0 0.0 0.5 0.0 1.0 1.5 2.0 2.5 ST Depression mm None Non-Angina Atypical Angina 3.0 Typical Angina Men 50 - 59 100 90 80 70 60 50 40 30 20 10 0 0.5 1.0 1.5 2.0 2.5 ST Depression mm None Non-Angina Atypical Angina 3.0 Typical Angina Men 60 - 69 100 % Probabilty CAD % Probabilty CAD 90 0.0 0.5 1.0 1.5 Non-Angina 80 70 60 50 40 30 20 10 0 0.0 2.0 ST Depression mm None 70 60 50 40 30 20 10 0 Atypical Angina 2.5 0.5 3.0 1.0 1.5 2.0 ST Depression mm Typical Angina None Non-Angina Atypical Angina 2.5 3.0 Typical Angina Diamond and Forrester. N. Engl. J. Med. 1350-7, 1979 2-5-2017 Eduard van den Berg, cardio.nl 46 The Likelihood Ratio • Ratio of two proportions: The proportion who have a particular test result (e.g. positive, negative, high probability) among those with a disease divided by The proportion who have the same test result among those without the disease LR = TEST RESULT/DISEASE + TEST RESULT/DISEASE – 2-5-2017 Keyvan Concepts Taught Eduard den Berg, cardio.nl 47 Incremental value of a test ROC curve 2-5-2017 Eduard van den Berg, cardio.nl 48 A global χ2 model showing the incremental value of ischaemic burden assessed by stress echocardiography over clinical assessment and stress ECG in all patients (A) and in the exercise cohort (B). Chelliah R et al. Eur J Echocardiogr 2010;11:875-882 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2010. For permissions please email: [email protected] 2-5-2017 Eduard van den Berg, cardio.nl 49 Sensitivity and Specificity a Sens ac d Spec bd 2-5-2017 Disease D Test Result + Eduard van den Berg, cardio.nl “Gold standard” + a c b d 50 Positive & Negative Predictive Value • PV (+): positive predictive value • PV (-): negative predictive value a PV () ab d PV () cd 2-5-2017 Test Result + - Disease D + a b c d a /(a c) LikelihoodRatio( LR) b /(b d ) Eduard van den Berg, cardio.nl 51 Posterior odds When combined with information on the prior probability of a disease*, LRs can be used to determine the predictive value of a particular test result: Posterior odds = Prior odds x Likelihood ratio *expressing the prior probability [p] of a disease as the prior odds [p/(1-p)] of that disease. Conversely, if the odds of a disease are x/y, the probability of the disease is x / (x + y) 2-5-2017 Eduard van den Berg, cardio.nl 52 Choice of a cut-off point for continuous results Consider the implications of the two possible errors: • If false-positive results must be avoided (such as the test result being used to determine whether a patient undergoes dangerous surgery), then the cutoff point might be set to maximize the test's specificity • If false-negative results must be avoided (as with screening for neonatal phenylketonuria), then the cutoff should be set to ensure a high test sensitivity 2-5-2017 Eduard van den Berg, cardio.nl 53 Choice of a cut-off point for continuous results • Using receiver operator characteristic (ROC) curves: – Selects several cut-off points, and determines the sensitivity and specificity at each point – Then, graphs sensitivity (true-positive rate) as a function of 1-specificity (false-positive rate) • Usually, the best cut-off point is where the ROC curve "turns the corner” 2-5-2017 Eduard van den Berg, cardio.nl 54 RECEIVER OPERATING CHARACTERISTIC (ROC) curve • ROC curves (Receiver Operator Characteristic) • Ex. SGPT and Hepatitis SGPT D+ D- Sum < 50 10 190 200 50-99 15 135 150 100-149 25 65 90 150-199 30 30 60 200-249 35 15 50 250-299 120 10 130 >300 65 5 70 Sum 300 450 750 Sensitivity 1 1 1-Specificity 2-5-2017 Eduard van den Berg, cardio.nl 55